Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
EditorialEDITORIALS
Open Access

The Eyeball Test

Bobby D. Nossaman
Ochsner Journal June 2023, 23 (2) 100-103; DOI: https://doi.org/10.31486/toj.23.5035
Bobby D. Nossaman
1Department of Anesthesiology and Perioperative Medicine, Ochsner Clinic Foundation, New Orleans, LA
2The University of Queensland Medical School, Ochsner Clinical School, New Orleans, LA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

THE RECOMMENDATION FOR INTRAVENOUS FLUIDS DURING SURGERY BEGINS IN NEW ORLEANS

The administration of intravenous fluids, crystalloids and colloids, has been an integral part of care for most surgical procedures, yet the replacement volume needed to maintain intravascular normovolemia continues to be a daily issue for most anesthesiologists.1 Although surgical procedures advanced following the introduction of ether anesthesia in the 1860s,2 intravenous fluids were only first proposed for surgery in 1924 by Dr Rudolph Matas of New Orleans to “restore the vascular equilibrium and rally the patient until the defensive cardiovascular mechanism has had time to assert itself….”3 In Matas’ day, the common methods for rehydrating patients unable to tolerate oral fluids were proctoclysis or hypodermoclysis, methods that were not always successful. Matas recommended the venoclysis route, with the intravenous infusion continued guttatim for as long as circulatory doubt existed.3 However, case descriptions of intravenous hydration included patients developing congestion of the lungs and heart when fluid was rapidly administered, hence Matas’ recommendation of a “drop by drop” rate of infusion.3-5 These early descriptions were observed in critically ill patients, and the understanding of ischemia-reperfusion syndrome may not have been known.3-5

THE DEBATE CONTINUES: WET OR DRY?

What is the right fluid balance for pulmonary resection procedures or for surgical procedures in general? The study of perioperative fluid therapy has increased in recent years as studies show that a fluid administration strategy can influence postoperative outcomes.6-12 Historically, the development of postpneumonectomy pulmonary edema as originally described by Zeldin, Normandin, and colleagues13 demonstrated higher complication rates when associated with excessive intravenous fluid therapy. Consequently, Zeldin et al and others recommended restricting the administration of intravenous fluids during pulmonary surgery.13-17 Other researchers, however, could not associate postpneumonectomy pulmonary edema with excessive intravenous fluid administration.18 In contrast, restricting fluid therapy risks inadequate organ perfusion with worse postoperative outcomes.19 Although the goal is to maintain intravascular normovolemia,20,21 the classic measures of intraoperative systemic hemodynamics and urine output do not provide satisfactory measures of intravascular normovolemia.22 Furthermore, investigations with the use of complex monitoring instruments to measure perioperative intravascular volume status have not answered this need,22 hence the continued use of guidelines rather than individualization measures to maintain intravascular normovolemia during the surgical procedure.15-17

THE USE OF VOLUMETRIC CURVES TO STUDY OUTCOMES

Bellamy20 and Bundgaard-Nielsen, Secher, and Kehlet21 proposed using volumetric dose-response curves to associate perioperative fluid administration with the incidence of postoperative morbidities. We agree with that concept. The authors proposed that the volumetric curves would be shaped in the form of a U, with the limbs of the U representing increased morbidities and the optimum fluid administration range located at the bottom of the U.20,21 The approach in our study was to examine the dose-response relationships to previously reported adverse events to determine the optimum intraoperative fluid administration rates23 and then compare these findings to other lung resection studies that reported their analyses with conventional summation statistics.24-27

In our study, the associations of the intraoperative crystalloid administration rate (mL/kg/hr) to previously reported adverse events were in the shapes of J-curves (see Figures 1 through 7 in our paper “Rate of Intraoperative Crystalloid Administration During Thoracic Surgery Is Causal in Reducing Postoperative Hospital Length of Stay,” doi.org/10.31486/toj.22.0113)23 rather than the hypothesized U-curves.20,21 J-curves are not a new concept, as they have been used in the medical literature to optimize blood pressure therapy28-31; to examine relationships between alcohol intake and noncardiogenic strokes,32,33 between plasma low-density lipoprotein concentrations and recurrent coronary events,34 and between pediatric serum lead levels and intellectual development35-37; and to investigate the role of body mass index on the incidences of cancer, hip fractures, and mortality.38-41

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Knotted spline graph showing the duration of postoperative hospital length of stay relative to the intraoperative crystalloid administration rate (mL/kg/hr).

CAN THE SHAPE OF CURVES ALLOW PREDICTION?

In our study, postoperative hospital length of stay was fitted to intraoperative crystalloid administration rate (Figure 1 in our paper “Rate of Intraoperative Crystalloid Administration During Thoracic Surgery Is Causal in Reducing Postoperative Hospital Length of Stay,” doi.org/10.31486/toj.22.0113).23 However, when using a different statistical fitting tool, knotted splines on this same association, a different fit is obtained (Figure 1 in this editorial). This fitted line is now under less summation constraints, and 3 patterns begin to emerge. In the intraoperative crystalloid administration rate range 0 to 10 mL/kg/hr, a higher mean of postoperative hospital length of stay is observed and the highest number of outliers (defined below). A second group between 10 to 20 mL/kg/hr has a lower fitted mean and a lower number of outliers with fewer extreme values when compared to the 0 to 10 mL/kg/hr group. A third group develops once the fitted line crosses into the intraoperative crystalloid administration of 20 mL/kg/hr. The associations viewed with knotted splines analysis suggest ideal administration rates of 20 to 30 mL/kg/hr, as no further reduction in postoperative hospital length of stay was observed: an eyeball test.42 However, these observations need further investigation.

We can also examine the range of postoperative hospital length of stay with another statistical tool, the outlier plot (Figure 2 in this editorial). According to this histogram/outlier plot, the outliers begin to develop when the postoperative hospital length of stay is >10 days. When the outlier values from the histogram/outlier plot are highlighted on the knotted spline graph, all outliers are below the 20 mL/kg/hr intraoperative crystalloid administration rate (Figure 3 in this editorial) with no outliers above 20 mL/kg/hr.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Histogram with outlier box plot of postoperative hospital length of stay in 222 consecutive patients following thoracic surgery. d, days.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Knotted spline graph showing the postoperative hospital length of stay outliers relative to the intraoperative crystalloid administration rate (mL/kg/hr).

CONCLUSION

The use of dose-response curves allows investigators to visualize optimal intraoperative crystalloid infusion rates and use these results to develop intraoperative fluid management guidelines for this patient population. This approach provides clinical information that cannot be determined when data are solely presented as summations. This method provides an additional tool to improve our understanding of perioperative medicine.

ACKNOWLEDGMENTS

The author has no financial or proprietary interest in the subject matter of this article.

  • ©2023 by the author(s); Creative Commons Attribution License (CC BY)

©2023 by the author(s); licensee Ochsner Journal, Ochsner Clinic Foundation, New Orleans, LA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (creativecommons.org/licenses/by/4.0/legalcode) that permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

REFERENCES

  1. 1.↵
    1. Malbrain MLNG,
    2. Langer T,
    3. Annane D,
    4. et al.
    Intravenous fluid therapy in the perioperative and critical care setting: executive summary of the International Fluid Academy (IFA). Ann Intensive Care. 2020;10(1):64. doi: 10.1186/s13613-020-00679-3
    OpenUrlCrossRef
  2. 2.↵
    1. Stone ME,
    2. Meyer MR,
    3. Alston TA
    . Elton Romeo Smilie, the not-quite discoverer of ether anesthesia. Anesth Analg. 2010;110(1):195-197. doi: 10.1213/ane.0b013e3181af7f9a
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Matas R
    . The continued intravenous “drip”: with remarks on the value of continued gastric drainage and irrigation by nasal intubation with a gastroduodenal tube (jutte) in surgical practice. Ann Surg. 1924;79(5):643-661. doi: 10.1097/00000658-192405000-00001
    OpenUrlCrossRefPubMed
  4. 4.
    1. Bailey H,
    2. Carnow JM
    . Continuous intravenous saline. Br Med J. 1934;1(3809):11-13. doi: 10.1136/bmj.1.3809.11
    OpenUrlFREE Full Text
  5. 5.↵
    1. Hendon GA
    . Venoclysis. JAMA. 1930;95(16):1175–1178. doi: 10.1001/jama.1930.02720160035011
    OpenUrlCrossRef
  6. 6.↵
    1. Holte K,
    2. Sharrock NE,
    3. Kehlet H
    . Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth. 2002;89(4):622-632. doi: 10.1093/bja/aef220
    OpenUrlCrossRefPubMed
  7. 7.
    1. Vercueil A,
    2. Grocott MP,
    3. Mythen MG
    . Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients. Transfus Med Rev. 2005;19(2):93-109. doi: 10.1016/j.tmrv.2004.11.006
    OpenUrlCrossRefPubMed
  8. 8.
    1. Grocott MPW,
    2. Mythen MG,
    3. Gan TJ
    . Perioperative fluid management and clinical outcomes in adults. Anesth Analg. 2005;100(4):1093-1106. doi: 10.1213/01.ANE.0000148691.33690.AC
    OpenUrlCrossRefPubMed
  9. 9.
    1. Holte K,
    2. Kehlet H
    . Compensatory fluid administration for preoperative dehydration—does it improve outcome? Acta Anaesthesiol Scand. 2002;46(9):1089-1093. doi: 10.1034/j.1399-6576.2002.460906.x
    OpenUrlCrossRefPubMed
  10. 10.
    1. Holte K,
    2. Kehlet H
    . Fluid therapy and surgical outcomes in elective surgery: a need for reassessment in fast-track surgery. J Am Coll Surg. 2006;202(6):971-989. doi: 10.1016/j.jamcollsurg.2006.01.003
    OpenUrlCrossRefPubMed
  11. 11.
    1. Chappell D,
    2. Jacob M,
    3. Hofmann-Kiefer K,
    4. Conzen P,
    5. Rehm M
    . A rational approach to perioperative fluid management. Anesthesiology. 2008;109(4):723-740. doi: 10.1097/ALN.0b013e3181863117
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Brandstrup B
    . Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol. 2006;20(2):265-283. doi: 10.1016/j.bpa.2005.10.007
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Zeldin RA,
    2. Normandin D,
    3. Landtwing D,
    4. Peters RM
    . Postpneumonectomy pulmonary edema. J Thorac Cardiovasc Surg. 1984;87(3):359-365.
    OpenUrlPubMed
  14. 14.
    1. Møller AM,
    2. Pedersen T,
    3. Svendsen PE,
    4. Engquist A
    . Perioperative risk factors in elective pneumonectomy: the impact of excess fluid balance. Eur J Anaesthesiol. 2002;19(1):57-62. doi: 10.1017/s0265021502000091
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Assaad S,
    2. Popescu W,
    3. Perrino A
    . Fluid management in thoracic surgery. Curr Opin Anaesthesiol. 2013;26(1):31-39. doi: 10.1097/ACO.0b013e32835c5cf5
    OpenUrlCrossRef
  16. 16.
    1. Searl CP,
    2. Perrino A
    . Fluid management in thoracic surgery. Anesthesiol Clin. 2012;30(4):641-655. doi: 10.1016/j.anclin.2012.08.009
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Şentürk M,
    2. Orhan Sungur M,
    3. Sungur Z
    . Fluid management in thoracic anesthesia. Minerva Anestesiol. 2017;83(6):652-659. doi: 10.23736/S0375-9393.17.11760-8
    OpenUrlCrossRef
  18. 18.↵
    1. Turnage WS,
    2. Lunn JJ
    . Postpneumonectomy pulmonary edema. A retrospective analysis of associated variables. Chest. 1993;103(6):1646-1650. doi: 10.1378/chest.103.6.1646
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Slinger P
    . Fluid management during pulmonary resection surgery. Ann Card Anaesth. 2002;5(2):220-224.
    OpenUrlPubMed
  20. 20.↵
    1. Bellamy MC
    . Wet, dry or something else? Br J Anaesth. 2006;97(6):755-757. doi: 10.1093/bja/ael290
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Bundgaard-Nielsen M,
    2. Secher NH,
    3. Kehlet H
    . 'Liberal' vs. 'restrictive' perioperative fluid therapy—a critical assessment of the evidence. Acta Anaesthesiol Scand. 2009;53(7):843-851. doi: 10.1111/j.1399-6576.2009.02029.x
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Bundgaard-Nielsen M,
    2. Holte K,
    3. Secher NH,
    4. Kehlet H
    . Monitoring of peri-operative fluid administration by individualized goal-directed therapy. Acta Anaesthesiol Scand. 2007;51(3):331-340. doi: 10.1111/j.1399-6576.2006.01221.x
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Smith MT,
    2. Peairs AD,
    3. Nossaman BD
    . Rate of intraoperative crystalloid administration during thoracic surgery is causal in reducing postoperative hospital length of stay. Oschsner J. 2023;23(2). doi: 10.31486/toj.22.0113
    OpenUrlCrossRef
  24. 24.↵
    1. Licker M,
    2. de Perrot M,
    3. Spiliopoulos A,
    4. et al.
    Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg. 2003;97(6):1558-1565. doi: 10.1213/01.ANE.0000087799.85495.8A
    OpenUrlCrossRefPubMed
  25. 25.
    1. Licker M,
    2. Diaper J,
    3. Villiger Y,
    4. et al.
    Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi: 10.1186/cc7762
    OpenUrlCrossRefPubMed
  26. 26.
    1. Matot I,
    2. Dery E,
    3. Bulgov Y,
    4. Cohen B,
    5. Paz J,
    6. Nesher N
    . Fluid management during video-assisted thoracoscopic surgery for lung resection: a randomized, controlled trial of effects on urinary output and postoperative renal function. J Thorac Cardiovasc Surg. 2013;146(2):461-466. doi: 10.1016/j.jtcvs.2013.02.015
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Arslantas MK,
    2. Kara HV,
    3. Tuncer BB,
    4. et al.
    Effect of the amount of intraoperative fluid administration on postoperative pulmonary complications following anatomic lung resections. J Thorac Cardiovasc Surg. 2015;149(1):314-321.e1. doi: 10.1016/j.jtcvs.2014.08.071
    OpenUrlCrossRef
  28. 28.↵
    1. Ahluwalia M,
    2. Bangalore S
    . Management of hypertension in 2017: targets and therapies. Curr Opin Cardiol. 2017;32(4):413-421. doi: 10.1097/HCO.0000000000000408
    OpenUrlCrossRef
  29. 29.
    1. Dudenbostel T,
    2. Oparil S. J
    Curve in Hypertension. Curr Cardiovasc Risk Rep. 2012;6(4):281-290. doi: 10.1007/s12170-012-0246-0
    OpenUrlCrossRef
  30. 30.
    1. Cruickshank J
    . The J-curve in hypertension. Curr Cardiol Rep. 2003;5(6):441-452. doi: 10.1007/s11886-003-0105-1
    OpenUrlCrossRefPubMed
  31. 31.↵
    The J-curve phenomenon and the treatment of hypertension. JAMA. 1991;266(1):64-66.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Shiotsuki H,
    2. Saijo Y,
    3. Ogushi Y,
    4. Kobayashi S
    ; Japan Standard Stroke Registry Study Group. Relationships between alcohol intake and ischemic stroke severity in sex stratified analysis for Japanese acute stroke patients. J Stroke Cerebrovasc Dis. 2019;28(6):1604-1617. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.034
    OpenUrlCrossRef
  33. 33.↵
    1. Wandeler G,
    2. Kraus D,
    3. Fehr J,
    4. et al.
    The J-curve in HIV: low and moderate alcohol intake predicts mortality but not the occurrence of major cardiovascular events. J Acquir Immune Defic Syndr. 2016;71(3):302-309. doi: 10.1097/QAI.0000000000000864
    OpenUrlCrossRef
  34. 34.↵
    1. Sacks FM,
    2. Moyé LA,
    3. Davis BR,
    4. et al.
    Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation. 1998;97(15):1446-1452. doi: 10.1161/01.cir.97.15.1446
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Jusko TA,
    2. Henderson CR,
    3. Lanphear BP,
    4. Cory-Slechta DA,
    5. Parsons PJ,
    6. Canfield RL
    . Blood lead concentrations < 10 microg/dL and child intelligence at 6 years of age. Environ Health Perspect. 2008;116(2):243-248. doi: 10.1289/ehp.10424
    OpenUrlCrossRefPubMed
  36. 36.
    1. Lanphear BP,
    2. Hornung R,
    3. Khoury J,
    4. et al.
    Low-level environmental lead exposure and children's intellectual function: an international pooled analysis [published correction appears in Environ Health Perspect. 2019 Sep;127(9):99001]. Environ Health Perspect. 2005;113(7):894-899. doi: 10.1289/ehp.7688
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Canfield RL,
    2. Henderson CR Jr.,
    3. Cory-Slechta DA,
    4. Cox C,
    5. Jusko TA,
    6. Lanphear BP
    . Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med. 2003;348(16):1517-1526. doi: 10.1056/NEJMoa022848
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Nafiu OO,
    2. Kheterpal S,
    3. Moulding R,
    4. et al.
    The association of body mass index to postoperative outcomes in elderly vascular surgery patients: a reverse J-curve phenomenon. Anesth Analg. 2011;112(1):23-29. doi: 10.1213/ANE.0b013e3181fcc51a
    OpenUrlCrossRefPubMed
  39. 39.
    1. Hong S,
    2. Yi SW,
    3. Sull JW,
    4. Hong JS,
    5. Jee SH,
    6. Ohrr H
    . Body mass index and mortality among Korean elderly in rural communities: Kangwha Cohort Study. PLoS One. 2015;10(2):e0117731. doi: 10.1371/journal.pone.0117731
    OpenUrlCrossRefPubMed
  40. 40.
    1. Hong JS,
    2. Yi SW,
    3. Yi JJ,
    4. Hong S,
    5. Ohrr H
    . Body mass index and cancer mortality among Korean older middle-aged men: a prospective cohort study. Medicine (Baltimore). 2016;95(21):e3684. doi: 10.1097/MD.0000000000003684
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Kim SH,
    2. Yi SW,
    3. Yi JJ,
    4. Kim YM,
    5. Won YJ
    . Association between body mass index and the risk of hip fracture by sex and age: a prospective cohort study. J Bone Miner Res. 2018;33(9):1603-1611. doi: 10.1002/jbmr.3464
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Welke KF
    . The eyeball test: can the blind leading the blind see better than the statistician? Circ Cardiovasc Qual Outcomes. 2014;7(1):11-12. doi: 10.1161/CIRCOUTCOMES.113.000760
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Ochsner Journal: 23 (2)
Ochsner Journal
Vol. 23, Issue 2
Jun 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Eyeball Test
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Eyeball Test
Bobby D. Nossaman
Ochsner Journal Jun 2023, 23 (2) 100-103; DOI: 10.31486/toj.23.5035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Eyeball Test
Bobby D. Nossaman
Ochsner Journal Jun 2023, 23 (2) 100-103; DOI: 10.31486/toj.23.5035
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • THE RECOMMENDATION FOR INTRAVENOUS FLUIDS DURING SURGERY BEGINS IN NEW ORLEANS
    • THE DEBATE CONTINUES: WET OR DRY?
    • THE USE OF VOLUMETRIC CURVES TO STUDY OUTCOMES
    • CAN THE SHAPE OF CURVES ALLOW PREDICTION?
    • CONCLUSION
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Xavier Ochsner College of Medicine – “The Time Is Always Right To Do What Is Right”
  • A Look Back at the Second Generation of Ochsner Research
  • The Case for Understanding Interdisciplinary Relationships in Health Care
Show more EDITORIALS

Similar Articles

Ochsner Journal Blog

Current Post

Be Careful Where You Publish -- Part 2

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2025 Ochsner Clinic Foundation

Powered by HighWire